Fund HoldingsKrensavage Asset Management, LLC

Total Portfolio Value
$283.1K
Total Bought
$32.6K
Total Sold
$19.6K
Net Transaction
+$13.0K
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
ENANTA PHARMACEUTICALS INC2,114,4442,766,390+651,946254415.41%+18
BIOMARIN PHARMACEUTICAL INC(BMRN)405,450524,786+119,336223111.02%+9
JAZZ PHARMACEUTICALS PLC(JAZZ)167,816167,8160222910.08%+6
VANDA PHARMACEUTICALS INC1,180,3881,180,38806103.68%+5
INDIVIOR PLC339,532339,53208124.30%+4
AVADEL PHARMACEUTICALS955,860855,860-100,00015186.51%+4
CARDINAL HEALTH INC(CAH)73,74573,745012155.35%+4
UNITED THERAPEUTICS CORP(UTHR)97,64691,282-6,364414415.71%+4
ULTRAGENYX PHARMACEUTICAL IN(RARE)0149,634+149,634031.22%+3
BIONTECH SE-ADR(BNTX)79,36699,523+20,157893.35%+2
REGENERON PHARMACEUTICALS(REGN)4,0004,0000231.09%+1
SANOFI-ADR(SNY)323,946323,946015165.54%0
BIOGEN INC(BIIB)10,00010,0000120.62%0
EXELIXIS INC(EXEL)518,526493,526-25,00021227.64%0
EVOLUS INC100,000100,0000110.23%0
SUPERNUS PHARMACEUTICALS INC(SUPN)363,479313,499-49,98017165.50%-2
ALKERMES PLC(ALKS)207,822107,822-100,000631.07%-3
GSK PLC-SPON ADR(GSK)271,72996,729-175,0001251.68%-7
Page 1 of 1